Karoline Fuchs
Papers
1
Total Citations
80
H-Index
1
About
Karoline Fuchs is a pioneering structural biochemist whose work has fundamentally advanced our understanding of neurotransmitter receptor architecture, particularly the GABAA receptor—a critical target for neurological drugs. Her landmark 2011 study, "Deep Amino Acid Sequencing of Native Brain GABAA Receptors Using High-Resolution Mass Spectrometry," overcame formidable technical barriers to sequence low-abundance, integral membrane proteins. By systematically optimizing solubilization, purification, enzymatic digestion, and chromatographic separation, Fuchs achieved the first comprehensive mass spectrometric sequencing of native GABAA receptor transmembrane domains—a feat previously considered intractable. This work, cited over 80 times, provided unprecedented molecular insights into receptor stoichiometry and post-translational modifications, directly informing drug design for anxiety, epilepsy, and sleep disorders. Her methodological innovations have since become foundational for studying other challenging membrane protein complexes. Fuchs’ contributions exemplify how rigorous analytical chemistry can unlock the molecular secrets of the brain, bridging the gap between protein structure and therapeutic intervention. Her research continues to inspire new approaches in neuroproteomics and membrane protein biology.
Research Focus
Key Achievements
Top Papers
- 1